Ulcerative Colitis Relapse Prevention Trial, Hypnosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The UCRPT is a randomized controlled trial to determine if a type of hypnotherapy will maintain remission in patients affected by Ulcerative Colitis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial

NCT00553163

Ulcerative Colitis

TERMINATED NA

Mind/Body Medicine and IBD Flare-Up

NCT00568256

Ulcerative Colitis

COMPLETED PHASE1

Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease

NCT03239704

Inflammatory Bowel Disease Ulcerative Colitis Crohn Disease

UNKNOWN NA

Contribution of a Non Medicamentous Approach by Hypnosis on Quality of Life in Crohn Disease

NCT03623932

Crohn Disease

UNKNOWN NA

Comparison Between Bowel Ultrasound-based Treat to Target Versus Routine Treat to Target Strategies in Ulcerative Colitis

NCT05735665

Ulcerative Colitis Chronic Moderate Ulcerative Colitis Chronic Severe

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the study is to determine whether hypnotherapy can serve as an effective therapy for patients with Ulcerative Colitis (UC), a chronic, relapsing and remitting inflammatory bowel disease (IBD).

The goal of this study is to determine if mind-body therapy is an effective complementary therapy for IBD, meaning a therapy to be used in conjunction with your standard treatment provided by your gastroenterologist. Standard treatment for UC often includes a combination approach and may include medications such as mesalamine, corticosteroids or immunomodulators. Mind-body therapy or hypnosis has been used to reduce stress and subsequent disease activity in patients with gastrointestinal diseases including IBD and Irritable Bowel Syndrome. It has also been shown to improve immune function and reduce inflammation in other health conditions such as cancer and arthritis.

In this study, patients with inactive UC will be randomized to one of three groups. Two groups will undergo one of two mind-body therapies, which may include relaxation techniques or other techniques aimed at identifying the impact of UC on your psyche along with standard care for their UC. The other group will undergo 8 weeks of standard care without mind-body therapy. Clinical assessment measures will be repeated at 8 weeks, 12 weeks, 24 weeks and 52 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis Inflammatory Bowel Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypnotherapy

Group Type ACTIVE_COMPARATOR

Hypnotherapy

Intervention Type BEHAVIORAL

8 weeks of gut-directed hypnotherapy

Standard care

Group Type PLACEBO_COMPARATOR

Standard care

Intervention Type BEHAVIORAL

8 weeks of standard of care

Mind Body Therapy

Group Type PLACEBO_COMPARATOR

Mind Body Therapy

Intervention Type BEHAVIORAL

8 weeks of mind-body therapy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hypnotherapy

8 weeks of gut-directed hypnotherapy

Intervention Type BEHAVIORAL

Standard care

8 weeks of standard of care

Intervention Type BEHAVIORAL

Mind Body Therapy

8 weeks of mind-body therapy

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HYP SC MB

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male and female patients between the ages of 18 and 70 of any ethnicity
* endoscopy-confirmed (within the past 2 years) mild or moderately severe Ulcerative Colitis (at time of previous flare)
* inactive disease at the time of recruitment:
* Mayo score \<2 with no subscale \>1
* no rectal bleeding
* Physician Global Assessment Score (PGA) = 0
* 2 weeks of baseline daily symptom diaries that support criteria for inactive disease
* documented disease flare within the past 1.5 years to enhance the opportunity to observe differences between groups in a 1-year trial .
* no medication or a stable dose of maintenance medication (i.e. mesalamine or sulfasalazine) for at least one month prior to enrollment.
* If taking maintenance medication: an increase in dose will be considered a relapse
* If taking no medication: initiation of any medication will be considered a relapse

Exclusion Criteria

* active disease
* daily rectal bleeding for past 7 days
* Mayo Score \> 2, any subscale \> 1
* PGA score \>0
* history of severe or fulminant UC
* most recent flare included \> 6 bloody stools a day
* history of of toxicity including fever, tachycardia, anemia or an elevated Erythrocyte sedimentation rate (ESR) ∙ history of continuous bleeding, blood transfusion requirement, abdominal tenderness and distension, and colonic dilation on abdominal plain films
* other gastrointestinal conditions
* Crohn's Disease (CD)
* short-bowel syndrome
* celiac sprue
* irritable bowel syndrome (IBS)
* renal or hepatic disease
* positive stool exam (bacteria, ova, parasites)
* C-difficile
* history of colon resection
* steroid-dependent, patients taking oral steroids within the past 30 days, topical steroids within the past week, quit smoking in the past 30 days given the known effects of smoking cessation on UC disease flare 23.
* contraindications for hypnotherapy
* unresolved history of physical or sexual abuse
* a current or past dissociative disorder (i.e. Borderline PD, PTSD)
* history of psychosis (including mania)
* history of psychiatric hospitalization, including for self-harm or SI/HI
* current substance abuse
* severe psychiatric disorder
* patients who are resistant to hypnosis as a result of religious or moral beliefs or any other reason

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No